![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1269656
¼¼°èÀÇ Àΰø ¸Á¸· ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°º°, Áúȯ ÀûÀÀÁõº°(¸Á¸·»ö¼Òº¯¼ºÁõ, ³ëÀÎȲ¹Ýº¯¼º), ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2022-2029³â)Global Artificial Retina Market Size study & Forecast, by Product, by Disease Indication (Retinitis Pigmentosa, Age-Related Macular Degeneration, by End User and Regional Analysis, 2022-2029 |
¼¼°è Àΰø ¸Á¸· ½ÃÀåÀº 2021³â ¾à 271¸¸ 1,400´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø±â°£ 2022-2029³â¿¡´Â 8.20% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Àΰø ¸Á¸·Àº Á¦ÇÑµÈ ½Ã·ÂÀ» ȸº¹½ÃŰ°í ¿òÁ÷ÀÌ´Â µ¿¾È ¹®ÀÚ¸¦ ÀÐÀ» ¼öÀÖ°Ô ÇØÁÖ´Â »ý¹° ÀÇÇÐ ÀåÄ¡ÀÔ´Ï´Ù. Àΰø ¸Á¸·Àº ¸Á¸·»ö¼Òº¯¼ºÁõ°ú °°Àº ½Ã·Â Àå¾Ö¸¦ Ä¡·áÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. ÀÌ ÀÓÇöõÆ®´Â À̹ÌÁö¸¦ Àü±â ½ÅÈ£·Î º¯È¯ÇÏ°í ½Å°æ ¼¼Æ÷·Î Àü´ÞÇÏ°í ºûÀÇ Á¸ÀçÇÏ¿¡ À̹ÌÁö¸¦ ½Äº°ÇÔÀ¸·Î½á ¹Ì·¡¿¡ ½Ã·ÂÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ³ôÀº ÅõÀÚ, ±Þ¼ÓÇÑ ±â¼ú Áøº¸, ³ë³â Àα¸ÀÇ Áõ°¡°¡ Àΰø ¸Á¸· ½ÃÀåÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.
2022³â 8¿ù ¹Ì±¹ ±¹¸³ ¾È°ú ¿¬±¸¼Ò(NEI)ÀÇ Åë°è¿¡ µû¸£¸é, ¸Á¸· ÀÌ¿µ¾çÁõÀº ¹Ì±¹¿¡¼ 4000¸í Áß 1¸íÀÇ ºñÀ²·Î ¹ßº´Çϰí ÀÖÀ¸¸ç, ù Áõ»óÀº ¾ß¸ÍÁõÀÔ´Ï´Ù. µû¶ó¼, ¸Á¸·»ö¼Òº¯¼ºÁõÀÇ À¯º´·üÀÇ Áõ°¡´Â ¿¹Ãø±â°£ µ¿¾È ½ÃÀåÀÇ À¯¸®ÇÑ ¼ºÀåÀ¸·Î À̾îÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ Áúº´°ü¸®¿¹¹æ¼¾ÅÍ(CDC)¿¡ µû¸£¸é ¹Ì±¹¿¡¼´Â 40¼¼ ÀÌ»óÀÇ ¿¬·ÉÃþ¿¡¼ ¾à 1,200¸¸¸íÀÌ ½Ã·ÂÀå¾Ö¿¡ ½Ã´Þ¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇコÄɾî ÁöÃâÀÇ Áõ°¡¿Í ¾È Áúȯ¿¡ °É¸®±â ½¬¿î ³ë³â Àα¸ÀÇ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷°ú Á¤ºÎÀÇ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ³ôÀº ÅõÀÚ, Çõ½ÅÀûÀÎ ¹ÙÀÌ¿À´Ð ºñÀü ½Ã½ºÅÛ µîÀÇ ±â¼úÀû Áøº¸°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª Àΰø ¸Á¸·ÀÇ ºñ¿ëÀÌ ³ô±â ¶§¹®¿¡ 2022-2029³â ¿¹Ãø±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÕ´Ï´Ù.
Àΰø ¸Á¸· ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì ¹× ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ¸Á¸· »ö¼Ò º¯¼º ȯÀÚÀÇ Áõ°¡¿Í °ß°íÇÑ ÇコÄɾî ÀÎÇÁ¶ó·Î Àΰø ¸Á¸· ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àεµ³ª Áß±¹ µî ±¹°¡ÀÇ Á¤ºÎ Áö¿ø Áõ°¡, 1ÀÎ´ç ¼Òµæ Áõ°¡, ÀÌ Æ¯Á¤ Áö¿ª ¾È°ú º´¿ø ¹× Ŭ¸®´Ð ¼ö Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ¿¹Ãø±â°£ µ¿¾È Å« ¼ºÀå·ü·Î È®´ë ¿¹»óµË´Ï´Ù.
º» ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇÏ°í ¾ÕÀ¸·Î ¼ö³â°£ÀÇ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼ÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.
10.2.10 Vivani Medical Inc.
Global Artificial Retina Market is valued at approximately USD 2711.4 thousand in 2021 and is anticipated to grow with a healthy growth rate of more than 8.20% over the forecast period 2022-2029. An artificial retina is a biomedical device that restores limited vision and enables people to read during mobility. Artificial retina helps to treat vision problems such as retinitis pigmentosa. This implant converts the image into an electrical signal that passes to the nerve cell to identify the image in the presence of light for better eyesight vision in the future. The high investment in R&D, rapid technological advancements, and a rise in the geriatric population are expanding the Artificial Retina Market.
According to National Eye Institute (NEI) statistics in August 2022, retinal dystrophy affects 1 in every 4000 people in the U.S., with the first symptom being night blindness. Therefore, a rise in the prevalence of retinitis pigmentosa is expected to lead to lucrative growth for the market over the forecast period. For instance, according to the U.S. Centers for Disease Control and Prevention (CDC), around 12 million people in the country, falling in the age category of 40 years and above, suffer from vision impairment. Also, growing healthcare expenditure and a rise in the geriatric population that is vulnerable to eye diseases fuel the market growth. Moreover, high investment in R&D by key players and the government and technical advancements such as innovative bionic vision systems are expected to drive market growth. However, The high cost of artificial retina stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Artificial Retina Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the Artificial Retina Market due to increasing cases of retinitis pigmentosa and strong healthcare infrastructure. Asia-Pacific is expected to expand at a significant growth rate over the forecast period owing to factors such as increasing government support in countries such as India and China, increasing per capita income and the rise in the number of ophthalmic hospitals and clinics in this particular region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
10.2.10 Vivani Medical Inc.